ClinicalTrials.Veeva

Menu

Brief Psychological Intervention for Suicidal Patients with Borderline Personality Disorder in the Emergency Department

C

Center for Addiction and Mental Health (CAMH)

Status

Not yet enrolling

Conditions

Borderline Personality Disorder (BPD)

Treatments

Behavioral: Treatment as usual
Behavioral: Gold Card Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06675461
2022-081

Details and patient eligibility

About

When in crisis, people with borderline personality disorder (BPD) frequently seek care in emergency departments (EDs) often presenting with suicide and self-harm behaviour. There is no established evidence-based brief treatment for patients with BPD in ED settings, however a 4-session treatment for people with personality disorders in ED settings was tested in Australia and showed promising results in reducing health care use and improving symptoms. A recent pilot feasibility randomized controlled trial (RCT) comparing this 4-session treatment to treatment as usual was conducted at the Centre for Addiction and Mental Health and preliminary findings have shown that the treatment is feasible to deliver and acceptable to both patients and clinicians. The proposed fully powered RCT will build on this pilot data to assess the efficacy of delivering this 4-session intervention in the ED for people with BPD who present with suicidal ideation or self-harm with the aim of reducing emergency health care use and improving BPD symptoms, functioning and quality of life.

Enrollment

180 estimated patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Must be deemed to have capacity to provide informed consent;
  2. Must sign and date the informed consent form;
  3. Stated willingness to comply with all study procedures;
  4. Aged 16 or older;
  5. Presenting to ED with self-harm and/or suicidal ideation;
  6. Meeting criteria for BPD on the International Personality Disorders Examination (IPDE).
  7. Endorsing a score of 1 or greater on the Suicide Ideation Attributes Scale (SIDAS).

Exclusion criteria

  1. Meeting DSM-5 criteria for severe substance use disorder, schizophrenia spectrum disorder or bipolar disorder I mania based on the Structured Clinical Interview for DSM-5 (SCID-5);
  2. IQ < 70 based on the Test of Premorbid Functioning (TOPF).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

180 participants in 2 patient groups

Treatment As Usual
Active Comparator group
Description:
Access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.
Treatment:
Behavioral: Treatment as usual
Gold Card Intervention
Experimental group
Description:
A 4-session manualized intervention consisting of weekly scheduled 50-minute 1:1 sessions focused on psycho-education, here-and-now problem solving and safety planning. One of the sessions can involve a significant other to provide psychoeducation about the disorder and to facilitate support.
Treatment:
Behavioral: Gold Card Intervention

Trial contacts and locations

0

Loading...

Central trial contact

Research Coordinator

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems